RVL Pharmaceuticals Plc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RVLPQ and buy or sell other stocks, ETFs, and their options commission-free!About RVLPQ
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, Lorzone, and M-72.
CEOBrian A. Markison, CPA
CEOBrian A. Markison, CPA
Employees125
Employees125
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1986
Founded1986
Employees125
Employees125
RVLPQ Key Statistics
Market cap11.14K
Market cap11.14K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.64K
Average volume1.64K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
The current RVL Pharmaceuticals Plc(RVLPQ) stock price is $0.00, with a market capitalization of 11.14K.
RVL Pharmaceuticals Plc(RVLPQ) stock opened on 2026-04-03 at —. The price climbed to — and dipped to —.
The RVL Pharmaceuticals Plc(RVLPQ)'s current trading volume is 0, compared to an average daily volume of 1.64K.
During the past year, RVL Pharmaceuticals Plc(RVLPQ) stock moved between $0.00 at its lowest and $0.00 at its peak.
During the past year, RVL Pharmaceuticals Plc(RVLPQ) stock moved between $0.00 at its lowest and $0.00 at its peak.
People also own
Based on the portfolios of people who own RVLPQ. This list is generated using Robinhood data, and it’s not a recommendation.